Pramipexole
规格
104632-26-0CAS 号
600-593-1EC 号
(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamineIUPAC 名称
C10H17N3S化学式
211.33 g/mol分子量
pramipexole; 104632-26-0; (-)-Pramipexole; Pramipexol; Mirapexin; Pramipexolum; Sifrol; SUD919CL2Y; Mirapex; U-98528E; Pramipexolum [Latin]; DTXSID6023496; (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; SUD-919CL2Y; CTC-501; 83619PEU5T; NSC-760426; 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-; CHEBI:8356; DTXCID203496; Pramipexolum (Latin); 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (S)-; (6S)-N'-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; Neliprax; Pipexus; 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole; RefChem:56732; N04BC05; 2 Amino 6 propylaminotetrahydrobenzothiazole; 4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine; (S)-N 6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (S)-Pramipexole; (S)-N6-Propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine; Oprymea; MFCD00869076; (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole; SND-919; PRAMIPEXOLE HCl; CHEMBL301265; (6S)-4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine; (S)-N6-Propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine; 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (6S)-; PRAMIPEXOLE HYDROCHLORIDE; NCGC00167441-01; SND 919; (6S)-N(6)-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; Pramipexol [Spanish]; SMR000449298; CAS-104632-26-0; SR-01000763219; Pramipexole (USAN/INN); SUD 919CL2Y; UNII-83619PEU5T; Pramipexole [USAN:INN:BAN]; (-) Pramipexole; 556801-24-2; Pramipexole (Standard); Spectrum_001838; 111GE001; SpecPlus_000820; PRAMIPEXOLE [MI]; Spectrum5_001453; PRAMIPEXOLE [INN]; PRAMIPEXOLE [USAN]; EC 600-593-1; PRAMIPEXOLE [VANDF]; SCHEMBL35376; GTPL953; KBioSS_002343; PRAMIPEXOLE [WHO-DD]; MLS000758250; MLS001423952; BIDD:GT0250; DivK1c_006916; orb1227067; orb1308531; HSDB 8253; HY-B0410R; KBio1_001860; KBio2_002340; KBio2_004908; KBio2_007476; (s)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole; GLXC-07798; HMS2051A21; HMS2090C15; HMS2232B03; HMS3884L19; (S)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzthiazole;(S)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzthiazole; HY-B0410; MSK11202; Tox21_112445; BDBM50116766; CX1349; EBC-26212; AKOS016843188; Tox21_112445_1; CCG-100823; DB00413; FP45322; NC00073; NSC 760426; NCGC00167441-02; NCGC00167441-03; NCGC00167441-08; NCGC00167441-10; DS-14807; SY009549; DB-038042; NS00098767; P2879; SW197453-4; D05575; EN300-150086; AB00053772-12; AB00053772-13; AB00053772_14; AB00053772_16; F225637; Q421304; SR-01000763219-5; SR-01000763219-6; BRD-K06388322-001-07-4; BRD-K06388322-312-02-6; (6S)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine; (s)-(-)-2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole; (6S)-N~6~-Propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (S)-N 6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine同义词
含有Pramipexole的产品
MIRAPEXIN 2,1 MG COMPRIMIDOS DE LIBERACION PROLONGADAMIRAPEXIN 2,1 MG COMPRIMIDOS DE LIBERACION PROLONGADAMIRAPEXIN 2,1 MG COMPRIMIDOS DE LIBERACION PROLONGADAMIRAPEXIN 2,1 MG COMPRIMIDOS DE LIBERACION PROLONGADAMIRAPEXIN 2,1 MG COMPRIMIDOS DE LIBERACION PROLONGADAMIRAPEXIN 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADAMIRAPEXIN 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADAMIRAPEXIN 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADAMIRAPEXIN 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADAMIRAPEXIN 1,05 MG COMPRIMIDOS DE LIBERACION PROLONGADAMIRAPEXIN 0,7 MG COMPRIMIDOSPRAMIPEXOL TEVA 0,7 mg COMPRIMIDOS EFG
第 1/7 页
销售Pramipexole的公司
CT
Công ty TNHH DRP InterViet NamBI
Boehringer Ingelheim International GmbhGermanySP
Sun Pharmaceutical Industries LtdUnited States第 1/2 页